Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments

References

• Schiffer R, Pope LE. Review of pseudobulbar affect including a novel and potential therapy. J. Neuropsychiatry Clin. Neurosci.17(4), 447–454 (2005).
   PubMed Web of Science ®Google Scholar
• Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB. Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs22(7), 531–545 (2008).
   PubMed Web of Science ®Google Scholar
• Gallagher JP. Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol. Scand.80(2), 114–117 (1989).
   PubMed Web of Science ®Google Scholar
• Kim SW, Shin IS, Kim JM, Lim SY, Yang SJ, Yoon JS. Mirtazapine treatment for pathological laughing and crying after stroke. Clin. Neuropharmacol.28(5), 249–251 (2005).
   PubMed Web of Science ®Google Scholar
• Pratt RT. An investigation of the psychiatric aspects of disseminated sclerosis. J. Neurol. Neurosurg. Psychiatry14(4), 326–335 (1951).
   PubMed Web of Science ®Google Scholar
• Feinstein A, Feinstein K, Gray T, O’Connor P. Prevalence of neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch. Neurol.54(9), 1116–1121 (1997).
   PubMed Web of Science ®Google Scholar
• Petracca GM, Jorge RE, Ación L, Weintraub D, Robinson RG. Frequency and correlates of involuntary emotional expression disorder in Parkinson’s disease. J. Neuropsychiatry Clin. Neurosci.21(4), 406–412 (2009).
   PubMed Web of Science ®Google Scholar
• Siddiqui MS, Fernandez HH, Garvan CW et al. Inappropriate crying and laughing in Parkinson disease and movement disorders. World J. Biol. Psychiatry10(3), 234–240 (2009).
   PubMed Web of Science ®Google Scholar
• Strowd RE, Cartwright MS, Okun MS, Haq I, Siddiqui MS. Pseudobulbar affect: prevalence and quality of life impact in movement disorders. J. Neurol.257(8), 1382–1387 (2010).
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Migliorelli R, Teson A et al. Prevalence and clinical correlates of pathological affective display in Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry59(1), 55–60 (1995).
   PubMed Web of Science ®Google Scholar
• Zeilig G, Drubach DA, Katz-Zeilig M, Karatinos J. Pathological laughter and crying in patients with closed traumatic brain injury. Brain Inj.10(8), 591–597 (1996).
   PubMed Web of Science ®Google Scholar
• Tateno A, Jorge RE, Robinson RG. Pathological laughing and crying following traumatic brain injury. J. Neuropsychiatry Clin. Neurosci.16(4), 426–434 (2004).
   PubMed Web of Science ®Google Scholar
• Sacco S, Sarà M, Pistoia F, Conson M, Albertini G, Carolei A. Management of pathologic laughter and crying in patients with locked-in syndrome: a report of 4 cases. Arch. Phys. Med. Rehabil.89(4), 775–778 (2008).
   PubMed Web of Science ®Google Scholar
• Arciniegas DB, Lauterbach EC, Anderson KE et al. The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting. CNS Spectr.10(5), 1–14 (2005).
   PubMed Web of Science ®Google Scholar
• Arciniegas DB, Topkoff J. The neuropsychiatry of pathologic affect: an approach to evaluation and treatment. Semin. Clin. Neuropsychiatry5(4), 290–306 (2000).
   PubMedGoogle Scholar
• Cummings JL, Arciniegas DB, Brooks BR et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr.11(Suppl. 6), 1–7 (2006).
   PubMed Web of Science ®Google Scholar
• Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am. J. Psychiatry150(2), 286–293 (1993).
   PubMed Web of Science ®Google Scholar
• Schiffer R, Herndon RM, Rudick RA. Treatment of pathological laughing and weeping with amitriptyline. N. Engl. J. Med.312(23), 1480–1482 (1985).
   PubMed Web of Science ®Google Scholar
• Phuong L, Garg S, Duda JE, Stern MB, Weintraub D. Involuntary emotional expression disorder (IEED) in Parkinson’s disease. Parkinsonism Relat. Disord.15(7), 511–515 (2009).
   PubMed Web of Science ®Google Scholar
• Calvert T, Knapp P, House A. Psychological associations with emotionalism after stroke. J. Neurol. Neurosurg. Psychiatry65(6), 928–929 (1998).
   PubMed Web of Science ®Google Scholar
• Seliger GM, Hornstein A, Flax J, Herbert J, Schroeder K. Fluoxetine improves emotional incontinence. Brain Inj.6(3), 267–270 (1992).
   PubMedGoogle Scholar
• Andersen G, Vestergaard K, Riis JO. Citalopram for post-stroke pathological crying. Lancet342(8875), 837–839 (1993).
   PubMed Web of Science ®Google Scholar
• Brown KW, Sloan RL, Pentland B. Fluoxetine as a treatment for post-stroke emotionalism. Acta Psychiatr. Scand.98(6), 455–458 (1998).
   PubMed Web of Science ®Google Scholar
• Iannaccone S, Ferini-Strambi L. Pharmacologic treatment of emotional lability. Clin. Neuropharmacol.19(6), 532–551 (1996).
   PubMed Web of Science ®Google Scholar
• Panzer MJ, Mellow AM. Antidepressant treatment of pathologic laughing or crying in elderly stroke patients. J. Geriatr. Psychiatry Neurol.5(4), 195–199 (1992).
   PubMed Web of Science ®Google Scholar
• Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull.65, 193–207 (2003).
   PubMed Web of Science ®Google Scholar
• Parvizi J, Anderson SW, Martin CO, Damasio H, Damasio AR. Pathological laughter and crying: a link to the cerebellum. Brain124(Pt 9), 1708–1719 (2001).
   PubMed Web of Science ®Google Scholar
• Ghaffar O, Chamelian L, Feinstein A. Neuroanatomy of pseudobulbar affect: a quantitative MRI study in multiple sclerosis. J. Neurol.255(3), 406–412 (2008).
   PubMed Web of Science ®Google Scholar
• Wilson SAK. Some problems in neurology. J. Neurol. Psychopathol.4, 299–333 (1924).
   PubMedGoogle Scholar
• Parvizi J, Coburn KL, Shillcutt SD et al. Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research. J. Neuropsychiatry Clin. Neurosci.21(1), 75–87 (2009).
   PubMed Web of Science ®Google Scholar
• Haiman G, Pratt H, Miller A. Brain responses to verbal stimuli among multiple sclerosis patients with pseudobulbar affect. J. Neurol. Sci.271(1–2), 137–147 (2008).
   PubMed Web of Science ®Google Scholar
• von Bohlen und Halbach O, Dermietzel R. Serotonin (5-hydroxytryptamine). In: Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects (Second Edition). von Bohlen und Halbach O, Dermietzel R (Eds). Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 132–143 (2006).
   Google Scholar
• Petty F, Davis LL, Kabel D, Kramer GL. Serotonin dysfunction disorders: a behavioral neurochemistry perspective. J. Clin. Psychiatry57(Suppl. 8), 11–16 (1996).
   PubMedGoogle Scholar
• von Bohlen und Halbach O, Dermietzel R. Glutamate and aspartate. In: Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects (Second Edition). von Bohlen und Halbach O, Dermietzel R (Eds). Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 90–107 (2006).
   Google Scholar
• Brooks BR, Thisted RA, Appel SH et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology63(8), 1364–1370 (2004).
   PubMed Web of Science ®Google Scholar
• Haiman G, Pratt H, Miller A. Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect. J. Clin. Psychopharmacol.29(5), 444–452 (2009).
   PubMed Web of Science ®Google Scholar
• Andersen G, Ingeman-Nielsen M, Vestergaard K, Riis JO. Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke25(5), 1050–1052 (1994).
   PubMed Web of Science ®Google Scholar
• Famularo G, Corsi FM, Minisola G, De Simone C, Nicotra GC. Cerebellar tumour presenting with pathological laughter and gelastic syncope. Eur. J. Neurol.14(8), 940–943 (2007).
   PubMed Web of Science ®Google Scholar
• Parvizi J, Schiffer R. Exaggerated crying and tremor with a cerebellar cyst. J. Neuropsychiatry Clin. Neurosci.19(2), 187–190 (2007).
   PubMed Web of Science ®Google Scholar
• Tei H, Sakamoto Y. Pontine infarction due to basilar artery stenosis presenting as pathological laughter. Neuroradiology39(3), 190–191 (1997).
   PubMed Web of Science ®Google Scholar
• Arif H, Mohr JP, Elkind MS. Stimulus-induced pathologic laughter due to basilar artery dissection. Neurology64(12), 2154–2155 (2005).
   PubMed Web of Science ®Google Scholar
• Oh K, Kim HJ, Kim BJ, Park KW, Lee DH. Pathological laughter as an unusual manifestation of acute stroke. Eur. Neurol.59(1–2), 83–84 (2008).
   PubMed Web of Science ®Google Scholar
• Lauterbach EC, Price ST, Spears TE, Jackson JG, Kirsh AD. Serotonin responsive and nonresponsive diurnal depressive mood disorders and pathological affect in thalamic infarct associated with myoclonus and blepharospasm. Biol. Psychiatry35(7), 488–490 (1994).
   PubMed Web of Science ®Google Scholar
• Ramnani N. The primate cortico-cerebellar system: anatomy and function. Nature Rev.7(7), 511–522 (2006).
   Web of Science ®Google Scholar
• Stoodley CJ, Schmahmann JD. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex46(7), 831–844 (2010).
   PubMed Web of Science ®Google Scholar
• Schmahmann JD, Weilburg JB, Sherman JC. The neuropsychiatry of the cerebellum – insights from the clinic. Cerebellum6(3), 254–267 (2007).
   PubMed Web of Science ®Google Scholar
• Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain121(Pt 4), 561–579 (1998).
   PubMed Web of Science ®Google Scholar
• Parvizi J, Joseph J, Press DZ, Schmahmann JD. Pathological laughter and crying in patients with multiple system atrophy-cerebellar type. Mov. Disord.22(6), 798–803 (2007).
   PubMed Web of Science ®Google Scholar
• Holtzman T, Rajapaksa T, Mostofi A, Edgley SA. Different responses of rat cerebellar Purkinje cells and Golgi cells evoked by widespread convergent sensory inputs. J. Physiol.574(Pt 2), 491–507 (2006).
   PubMed Web of Science ®Google Scholar
• Barmack NH, Yakhnitsa V. Functions of interneurons in mouse cerebellum. J. Neurosci.28(5), 1140–1152 (2008).
   PubMed Web of Science ®Google Scholar
• Crowley JJ, Fioravante D, Regehr WG. Dynamics of fast and slow inhibition from cerebellar Golgi cells allow flexible control of synaptic integration. Neuron63(6), 843–853 (2009).
   PubMed Web of Science ®Google Scholar
• Prsa M, Dash S, Catz N, Dicke PW, Thier P. Characteristics of responses of Golgi cells and mossy fibers to eye saccades and saccadic adaptation recorded from the posterior vermis of the cerebellum. J. Neurosci.29(1), 250–262 (2009).
   PubMed Web of Science ®Google Scholar
• Dean P, Porrill J, Ekerot CF, Jörntell H. The cerebellar microcircuit as an adaptive filter: experimental and computational evidence. Nat. Rev. Neurosci.11(1), 30–43 (2010).
   PubMed Web of Science ®Google Scholar
• Werling LL, Keller A, Frank JG, Nuwayhid SJ. A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder. Exp. Neurol.207(2), 248–257 (2007).
   PubMed Web of Science ®Google Scholar
• Kim JS. Pathologic laughter after unilateral stroke. J. Neurol. Sci.148(1), 121–125 (1997).
   PubMed Web of Science ®Google Scholar
• Ferentinos P, Paparrigopoulos T, Rentzos M, Evdokimidis I. Duloxetine for pathological laughing and crying. Int. J. Neuropsychopharmacol.12(10), 1429–1430 (2009).
   PubMed Web of Science ®Google Scholar
• Müller U, Murai T, Bauer-Wittmund T, von Cramon DY. Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Inj.13(10), 805–811 (1999).
   PubMed Web of Science ®Google Scholar
• Burns A, Russell E, Stratton-Powell H, Tyrell P, O’Neill P, Baldwin R. Sertraline in stroke-associated lability of mood. Int. J. Geriatr. Psychiatry14(8), 681–685 (1999).
   PubMed Web of Science ®Google Scholar
• Choi-Kwon S, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke37(1), 156–161 (2006).
   PubMed Web of Science ®Google Scholar
• Miller A, Panitch H. Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect. J. Neurol. Sci.259(1–2), 67–73 (2007).
   PubMed Web of Science ®Google Scholar
• Hackett ML, Yang M, Anderson CS, Horrocks JA, House A. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst. Rev. (2), CD003690 (2010).
   Google Scholar
• Murray V, von Arbin M, Bartfai A et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J. Clin. Psychiatry66(6), 708–716 (2005).
   PubMed Web of Science ®Google Scholar
• Panitch HS, Thisted RA, Smith RA et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann. Neurol.59(5), 780–787 (2006).
   PubMed Web of Science ®Google Scholar
• Pope LE, Khalil MH, Berg JE, Stiles M, Yakatan GJ, Sellers EM. Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers. J. Clin. Pharmacol.44(10), 1132–1142 (2004).
   PubMed Web of Science ®Google Scholar
• Bermack JE, Debonnel G. Distinct modulatory roles of σ receptor subtypes on glutamatergic responses in the dorsal hippocampus. Synapse55(1), 37–44 (2005).
   PubMed Web of Science ®Google Scholar
• Craviso GL, Musacchio JM. High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization. Mol. Pharmacol.23(3), 619–628 (1983).
   PubMed Web of Science ®Google Scholar
• Maurice T, Urani A, Phan VL, Romieu P. The interaction between neuroactive steroids and σ-1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res. Rev.37(1–3), 116–132 (2001).
   PubMed Web of Science ®Google Scholar
• Pioro EP, Brooks BR, Cummings J et al. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann. Neurol.68(5), 693–702 (2010).
   PubMed Web of Science ®Google Scholar
• Moore SR, Gresham LS, Bromberg MB, Kasarkis EJ, Smith RA. A self report measure of affective lability. J. Neurol. Neurosurg. Psychiatry63(1), 89–93 (1997).
   PubMed Web of Science ®Google Scholar
• Smith RA, Berg JE, Pope LE, Callahan JD, Wynn D, Thisted RA. Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients. Mult. Scler.10(6), 679–685 (2004).
   PubMed Web of Science ®Google Scholar
• Thisted RA, Klaff L, Schwartz SL et al. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study. Clin. Ther.28(10), 1607–1618 (2006).
   PubMed Web of Science ®Google Scholar
• Pioro EP, Brooks BR, Cummings J et al. Persistent efficacy of dextromethorphan (DM)/quinidine (Q) for pseudobulbar affect (PBA): results from a 12-Week, Open-Label Extension (OLE) Study. Presented at: 62nd American Academy of Neurology Annual Meeting. Toronto, Ontario, Canada, 10–17 April 2010.
   Google Scholar